{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T03:38:08Z","timestamp":1780803488918,"version":"3.54.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,17]]},"DOI":"10.7759\/cureus.9813","type":"journal-article","created":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T18:27:20Z","timestamp":1597688840000},"source":"Crossref","is-referenced-by-count":2,"title":["Adult-Onset Cerebral Adrenoleukodystrophy Without Adrenal Gland Involvement"],"prefix":"10.7759","author":[{"given":"Aniruddh","family":"Mannari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Wiggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghassan","family":"Bachuwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2013.11.023","article-title":"Pathophysiology of X-linked adrenoleukodystrophy","volume":"98","author":"Berger J","year":"2014","unstructured":"Berger J, Forss-Petter S, Eichler FS. Pathophysiology of X-linked adrenoleukodystrophy. Biochimie. 2014, 98:135-42. 10.1016\/j.biochi.2013.11.023","journal-title":"Biochimie"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.2010.00391.x","article-title":"Biochemical aspects of X-linked adrenoleukodystrophy","volume":"4","author":"Kemp S","year":"2010","unstructured":"Kemp S, Wanders R. Biochemical aspects of X-linked adrenoleukodystrophy. Brain Pathol. 2010, 4:831-7. 10.1111\/j.1750-3639.2010.00391.x","journal-title":"Brain Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ana.101","article-title":"Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening","volume":"1","author":"Bezman L","year":"2001","unstructured":"Bezman L, Moser AB, Raymond GV, et al.. Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann Neurol. 2001, 1:512-7. 10.1002\/ana.101","journal-title":"Ann Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-014-0486-0","article-title":"X-linked adrenoleukodystrophy: pathogenesis and treatment","volume":"14","author":"Engelen M","year":"2014","unstructured":"Engelen M, Kemp S, Poll-The B. X-linked adrenoleukodystrophy: pathogenesis and treatment. Curr Neurol Neurosci Rep. 2014, 14:486. 10.1007\/s11910-014-0486-0","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2016.01.003","article-title":"Endocrine dysfunction in X-linked adrenoleukodystrophy","volume":"45","author":"Burtman E","year":"2016","unstructured":"Burtman E, Regelmann M. Endocrine dysfunction in X-linked adrenoleukodystrophy. Endocrinol Metab Clin North Am. 2016, 45:295-309. 10.1016\/j.ecl.2016.01.003","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2016.68","article-title":"Newborn screening for X-linked adrenoleukodystrophy: evidence summary and advisory committee recommendation","volume":"19","author":"Kemper AR","year":"2016","unstructured":"Kemper AR, Brosco J, Comeau AM, et al.. Newborn screening for X-linked adrenoleukodystrophy: evidence summary and advisory committee recommendation. Genet Med. 2016, 19:121-6. 10.1038\/gim.2016.68","journal-title":"Genet Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1006\/mgme.1998.2779","article-title":"Accurate DNA-based diagnostic and carrier testing for X-linked adrenoleukodystrophy","volume":"2","author":"Boehm CD","year":"1999","unstructured":"Boehm CD, Cutting GR, Lachtermacher MB, Moser HW, Chong SS. Accurate DNA-based diagnostic and carrier testing for X-linked adrenoleukodystrophy. Mol Genet Metab. 1999, 2:128-36. 10.1006\/mgme.1998.2779","journal-title":"Mol Genet Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-329235","article-title":"Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report","volume":"7","author":"Miller WP","year":"2011","unstructured":"Miller WP, Rothman SM, Nascene D, et al.. Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report. Blood. 2011, 7:1971-8. 10.1182\/blood-2011-01-329235","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-304695","article-title":"Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude","volume":"84","author":"Dobson R","year":"2013","unstructured":"Dobson R, Ramagopalan S, Davis A, Giovannoni G. Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude. J Neurol Neurosurg Psychiatry. 2013, 84:909-14. 10.1136\/jnnp-2012-304695","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-52001-2.00012-1","article-title":"MRI mimics of multiple sclerosis","author":"Sanchez EA","year":"2014","unstructured":"Sanchez EA, Barkhof F. MRI mimics of multiple sclerosis. Handbook of Clinical Neurology. Douglas S. Goodin (ed): Elsevier, Amsterdam; 2014. 122:291-316. 10.1016\/B978-0-444-52001-2.00012-1"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.63.1.4","article-title":"X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy","volume":"63","author":"van Geel BM","year":"1997","unstructured":"van Geel BM, Assies J, Wanders RJA, Barth PG. X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy. J Neurol Neurosurg Psychiatry. 1997, 63:4. 10.1136\/jnnp.63.1.4","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2011.01.033","article-title":"Adult-onset adrenoleukodystrophy heralded by auditory hallucinations and delusions","volume":"52","author":"Furuhashi Y","year":"2011","unstructured":"Furuhashi Y, Ishikawa M. Adult-onset adrenoleukodystrophy heralded by auditory hallucinations and delusions. Psychosomatics. 2011, 52:492-3. 10.1016\/j.psym.2011.01.033","journal-title":"Psychosomatics"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1212\/01.CPJ.0000435751.17621.93","article-title":"Adult-onset adrenoleukodystrophy presenting after chemotherapy: no black and white matter","volume":"4","author":"Isaacs D","year":"2014","unstructured":"Isaacs D, Olmez I, Claassen DO. Adult-onset adrenoleukodystrophy presenting after chemotherapy: no black and white matter. Neurol Clin Pract. 2014, 4:168-70. 10.1212\/01.CPJ.0000435751.17621.93","journal-title":"Neurol Clin Pract"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.434","article-title":"Mild phenotype in an adult male with X\u2010linked adrenoleukodystrophy - case report","volume":"4","author":"Horn MA","year":"2016","unstructured":"Horn MA, Mikaelsen KB, Ferdinandusse S, et al.. Mild phenotype in an adult male with X\u2010linked adrenoleukodystrophy - case report. Clin Case Reports. 2016, 4:177-81. 10.1002\/ccr3.434","journal-title":"Clin Case Reports"},{"key":"ref15","article-title":"Classification of myelin disorders","author":"van der Knaap M","year":"2005","unstructured":"van der Knaap M, Valk J. Classification of myelin disorders. Magnetic Resonance of Myelination and Myelin Disorders. Springer, New York; 2005. 20-24."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001074","article-title":"Frequent occurrence of cerebral demyelination in adrenomyeloneuropathy","volume":"1","author":"De Beer M","year":"2014","unstructured":"De Beer M, Engelen M, Van Geel BM. Frequent occurrence of cerebral demyelination in adrenomyeloneuropathy. Neurology. 2014, 1:2227-31. 10.1212\/WNL.0000000000001074","journal-title":"Neurology"},{"key":"ref17","article-title":"X-linked adrenoleukodystrophy: the role of contrast-enhanced MR imaging in predicting disease progression","volume":"21","author":"Melhem ER","year":"2000","unstructured":"Melhem ER, Loes DJ, Georgiades CS, Raymond G V, Moser HW. X-linked adrenoleukodystrophy: the role of contrast-enhanced MR imaging in predicting disease progression. Am J Neuroradiol. 2000, 21:839-44.","journal-title":"Am J Neuroradiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awx016","article-title":"Long-term outcomes of allogeneic haematopoietic stem cell transplantation for adult cerebral X-linked adrenoleukodystrophy","volume":"140","author":"K\u00fchl J-S","year":"2017","unstructured":"K\u00fchl J-S, Suarez F, Gillett GT, et al.. Long-term outcomes of allogeneic haematopoietic stem cell transplantation for adult cerebral X-linked adrenoleukodystrophy. Brain. 2017, 140:953-66. 10.1093\/brain\/awx016","journal-title":"Brain"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2015.6","article-title":"Adenoassociated virus serotype 9-mediated gene therapy for x-linked adrenoleukodystrophy","volume":"23","author":"Gong Y","year":"2015","unstructured":"Gong Y, Mu D, Prabhakar S, et al.. Adenoassociated virus serotype 9-mediated gene therapy for x-linked adrenoleukodystrophy. Mol Ther. 2015, 23:824-34. 10.1038\/mt.2015.6","journal-title":"Mol Ther"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy","volume":"326","author":"Cartier N","year":"2009","unstructured":"Cartier N, Hacein-Bey-Abina S, Bartholomae CC, et al.. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science. 2009, 326:818-23. 10.1126\/science.1171242","journal-title":"Science"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/37741-adult-onset-cerebral-adrenoleukodystrophy-without-adrenal-gland-involvement","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:24:31Z","timestamp":1707506671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/37741-adult-onset-cerebral-adrenoleukodystrophy-without-adrenal-gland-involvement"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,17]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.9813","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,17]]}}}